Is Medacta a good company?
Medacta is widely recognized by medical technology analysts and orthopedic surgeons as a high-quality, innovative global medical device company specializing in joint replacement, spine surgery, and sports medicine products. Headquartered in Switzerland, the company distinguishes itself through advanced personalized surgical solutions, proprietary 3D-planning software, and robust educational programs for healthcare professionals. Its consistent revenue growth, high gross margins, and strong international adoption rates reflect its solid operational reputation.
Related FAQs
Marqeta, Inc. officially completed its initial public offering, pricing its shares at twenty-seven dollars each on June 8, 2021, with trading on the Nasdaq Global Select Market commencing on June 9, 2021 under the ticker symbol MQ.
Interns participating in corporate, clinical research, and scientific internship programs at Medpace earn hourly wages and stipends structured around academic qualifications, functional departments, and geographic work locations.
Francesco Siccardi, serving as the Chief Executive Officer of Medacta Group, receives a comprehensive annual remuneration package valued at approximately €2.00 million.
Datamatics Global Services Limited officially completed its initial public offering and listed its equity shares on Indian stock exchanges, including the Bombay Stock Exchange and National Stock Exchange, in 2004.
Medacta International was founded in 1999 by Alberto Siccardi in Castel San Pietro, Switzerland, starting as a specialized orthopaedic medical technology enterprise focused on designing, manufacturing, and distributing joint replacement systems, spin...
Medacta Group SA generates a strong annual net profit for the year scaling near 47.4 million euros, representing a stable net profit margin on overall business revenues.
Medacta SA, a global medical technology enterprise specializing in the design, manufacture, and distribution of orthopedic implants, neurosurgical systems, and personalized mobile health solutions, is based in Castel San Pietro, Switzerland.
Medacta International is a global medical technology enterprise that designs, manufactures, and distributes advanced orthopedic implants, surgical instruments, and specialized software solutions for joint replacement, spine surgery, and sports medici...
Medacta Group SA is a publicly traded corporation listed on the SIX Swiss Exchange under the ticker symbol MOVE.
Medacta Group SA officially completed its initial public offering and began trading its shares on the SIX Swiss Exchange on April 4, 2019, with an initial pricing of 96 Swiss francs per share.